The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 14
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte GLENN J. GORMLEY, KEITH D. KAUFMAN,
ELIZABETH STONER and JOANNE WALDSTREICHER
__________
Appeal No. 2004-0543
Application No. 10/010,678
__________
ON BRIEF
__________
Before SCHEINER, MILLS and GRIMES, Administrative Patent Judges.
SCHEINER, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on appeal under 35 U.S.C. ' 134 from the final rejection of
claims 28-37, the only claims remaining. Claims 28, 30, 33 and 36 are representative:
28. A method of treating androgenic alopecia comprising transdermally
administering to a person in need of such treatment a therapeutically effective amount
of a 5alpha-reductase 2 inhibitor.
30. The method according to claim 28, wherein the 5alpha-reductase 2 inhibitor
is transdermally administered by a transdermal skin patch.
33. A method of treating androgenic alopecia comprising transdermally
administering to a person in need of such treatment a therapeutically effective amount
of 17β-(N-tert-butylcarbamoyl)-4-aza-5α-androst-1-ene-3-one.
36. A transdermal skin patch comprising a therapeutically effective amount of a
5alpha-reductase 2 inhibitor.
The references relied on by the examiner are:
Page: 1 2 3 4 5 6 7 8 9 10 Next
Last modified: November 3, 2007